Trial Details

COMPLETED
Basic Information
Clinical ID c1079
Identifier NCT05602116
Trial Title ASC - Autism Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Autism Spectrum Disorder|Gastrointestinal Dysfunction|Leaky Gut Syndrome|Mesenchymal Stromal Cells|Inflammatory Bowel Diseases
Interventions DRUG: Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®)
Participant Information
Sponsor Cell to Cure ApS
City Aalborg
Country/Region Denmark
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2023-06-09
Primary Completion Date 2024-06-28
Completion Date 2024-09-20